A big Alzheimer’s drug trial now wrapping up could offer real hope — or crush it
(By Damian Garde for STAT) Scientists at Eli Lilly are racing to wrap up a clinical trial on a drug
Read More
Part D/Prescription Drugs
Out-of-pocket burden for breast cancer treatment varies across US
(By Kelly Gooch for Becker’s Hospital Review) Breast cancer chemotherapy costs vary widely across the United States, with patients taking
Read MoreDEA opts against ban on herbal supplement kratom
(By Alicia A. Cardwell of Associated Press for STAT) WASHINGTON — The Drug Enforcement Administration has reversed a plan to temporarily
Read MoreSenator demands federal agencies limit use of prescription fentanyl
(By David Armstrong for STAT) A US senator is urging federal agencies to limit the use of a prescription version
Read MoreRising drug prices are making hospitals feel ill
(By Ed Silverman for STAT) The rising cost of medicines is making some hospitals feel ill. Continue reading article here……
Read MoreHuge Valeant price hike on lead poisoning drug sparks anger
(By Ed Silverman for STAT) A drug used to treat lead poisoning is causing a toxic reaction among hospitals and
Read MoreRethinking Automatic Insurance Coverage For Preventive Health Care
(By Alison Kodjak for NPR) Three doctors who have led a task force that evaluates preventive medical services say the
Read MoreThis federal drug discount program is actually boosting cancer care costs
(By Debra Patt for STAT) Given its name, you’d expect the federal 340B Drug Discount Program1 to save money for
Read MoreTo stop FDA inspector, workers at Japanese drug maker formed a human barricade
(By Ed Silverman for STAT) Someone at Nippon Fine Chemical must have been very nervous when an investigator from the
Read MoreWhat outrage? Ariad raises price of its leukemia drug four times so far this year
(By Ed Silverman for STAT) At a time when drug makers are under intense scrutiny for their pricing, Ariad Pharmaceuticals
Read More